×
About 18,313 results

ALLMedicine™ Dengue Center

Research & Reviews  6,514 results

Sociodemographic and environmental factors associated with dengue, Zika, and chikunguny...
https://doi.org/10.1371/journal.pntd.0011197
PLoS Neglected Tropical Diseases; Dalvi APR, Gibson G et. al.

Mar 18th, 2023 - Among the emerging and reemerging arboviral diseases, Zika, dengue and chikungunya deserve special attention due to their wide geographical distribution and clinical severity. The three arboviruses are transmitted by the same vector and can presen...

Evolution of research funding for neglected tropical diseases in Brazil, 2004-2020.
https://doi.org/10.1371/journal.pntd.0011134
PLoS Neglected Tropical Diseases; Melo GBT, Angulo-Tuesta A et. al.

Mar 18th, 2023 - Neglected tropical diseases are a global public health problem. Although Brazil is largely responsible for their occurrence in Latin America, research funding on the subject does not meet the population's health needs. The present study analyzed t...

The rising cases of dengue amidst the prolonged monsoon in Pakistan: Challenges, effort...
https://doi.org/10.1097/JS9.0000000000000106
International Journal of Surgery (London, England); Khan HA, Malik UU et. al.

Mar 18th, 2023 - The rising cases of dengue amidst the prolonged monsoon in Pakistan: Challenges, efforts and recommendations.|2023|Khan HA,Malik UU,Yousuf J,Shahzad A,Ur Rehman M,|

Notes From the Field: First Evidence of Locally Acquired Dengue Virus Infection - Maric...
https://doi.org/10.15585/mmwr.mm7211a5
MMWR. Morbidity and Mortality Weekly Report; Kretschmer M, Collins J et. al.

Mar 18th, 2023 - Notes From the Field: First Evidence of Locally Acquired Dengue Virus Infection - Maricopa County, Arizona, November 2022.|2023|Kretschmer M,Collins J,Dale AP,Garrett B,Koski L,|

Standardized evaluation of Zika nucleic acid tests used in clinical settings and blood ...
https://doi.org/10.1371/journal.pntd.0011157
PLoS Neglected Tropical Diseases; Stone M, Bakkour S et. al.

Mar 18th, 2023 - Early detection of Zika virus (ZIKV) transmission within geographic regions informs implementation of community mitigation measures such as vector reduction strategies, travel advisories, enhanced surveillance among pregnant women, and possible im...

see more →

Guidelines  3 results

Dengue and Zika Virus Diagnostic Testing for Patients with a Clinically Compatible Illn...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581290
MMWR. Recommendations and Reports : Morbidity and Mortali... Sharp TM, Fischer M et. al.

Jun 14th, 2019 - Dengue and Zika viruses are closely related mosquitoborne flaviviruses with similar transmission cycles, distribution throughout the tropics and subtropics, and disease manifestations including fever, rash, myalgia, and arthralgia. For patients wi...

Best practices in dengue surveillance: a report from the Asia-Pacific and Americas Deng...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2982842
PLoS Neglected Tropical Diseases; Beatty ME, Stone A et. al.

Nov 26th, 2010 - Dengue fever is a virus infection that is spread by the Aedes aegypti mosquito and can cause severe disease especially in children. Dengue fever is a major problem in tropical and sub-tropical regions of the world. We invited dengue experts from a...

"Guidelines for the clinical evaluation of dengue vaccines in endemic areas": summary o...
https://doi.org/10.1016/j.vaccine.2008.05.058
Vaccine Edelman R, Hombach J

Jul 4th, 2008 - There is a pressing need for guidelines focused on the clinical evaluation of dengue vaccines in exposed populations, because Phase 1 and 2 clinical trials of dengue vaccines have begun, and Phase 3 field trials may be warranted soon. In response ...

see more →

Drugs  2 results see all →

Clinicaltrials.gov  275 results

Trial to Model Primary, Secondary, and Tertiary Dengue Using a Monovalent Vaccine
https://clinicaltrials.gov/ct2/show/NCT05691530

Mar 10th, 2023 - Study Description: Phase 1 trial wherein healthy adults with no (naive), one (primary heterotypic), or more than one (polytypic) previous natural dengue virus (DENV) infection(s) will be immunized with the DENV3 monovalent vaccine rDEN3delta30/31-...

Dengue 4 Human Infection Model (Dengue CVD 11000; DHIM-4)
https://clinicaltrials.gov/ct2/show/NCT05268302

Mar 9th, 2023 - The purpose of this research study is to test a weakened form of an experimental dengue virus challenge at different doses to test if participants develop symptoms or circulating virus in the blood (called viremia). When volunteers are exposed to ...

Clinical Bridging Study Between V181 (Dengue Quadrivalent Vaccine rDENVΔ30 [Live, Attenuated]) to Butantan Dengue Vaccine (Butantan-DV) in Healthy Adults 18 to 50 Years of Age in Brazil (V181-002)
https://clinicaltrials.gov/ct2/show/NCT05710224

Mar 2nd, 2023 - The purpose of this study is to demonstrate that V181 is safe and well tolerated and elicits an immune response that is non-inferior to that of Butantan-DV at Day 28 post-vaccination in adults 18 to 50 years of age in Brazil. The primary hypothesi...

A Cluster-randomized Trial to EValuate the Efficacy of Wolbachia-InfecTed Aedes Aegypti Mosquitoes in Reducing the Incidence of Arboviral Infection in Brazil (EVITA Dengue)
https://clinicaltrials.gov/ct2/show/NCT04514107

Feb 24th, 2023 - Study Design Introduction:This will be a parallel design cluster randomized controlled trial with 3 years (3 seasons) of follow-up from initial deployment of mosquitoes. The intervention will be routine control measures, as recommended by the Braz...

A Study of INO-A002 in Healthy Dengue Virus-naive Adults
https://clinicaltrials.gov/ct2/show/NCT03831503

Feb 21st, 2023 - This is a Phase 1, open label, single center, dose escalation study to evaluate the safety, tolerability and pharmacokinetic profile of dMAb-ZK190 following delivery of INO-A002 with Hylenex® recombinant delivered IM followed by EP in healthy adul...

see more →

News  510 results

Vital Signs: Trends in Reported Vectorborne Disease Cases - United States and Territories, 2004-2016
https://tools.cdc.gov/medialibrary/index.aspx#/media/id/380305

Vectorborne diseases are major causes of death and illness worldwide. In the United States, the most common vectorborne pathogens are transmitted by ticks or mosquitoes, including those causing Lyme disease; Rocky Mountain spotted fever; and West ...

Japan's Takeda Secures EU Nod for Its Dengue Vaccine
https://www.medscape.com/viewarticle/985250

Dec 12th, 2022 - LONDON (Reuters) - A dengue vaccine developed by Japanese drugmaker Takeda Pharmaceutical Co was authorised for use in the European Union on Thursday, making it the second approved inoculation against the mosquito-borne disease that causes million...

Dengue
https://tools.cdc.gov/medialibrary/index.aspx#/media/id/132504

Dengue is spread through Aedes aegypti and Aedes albopictus mosquito bites, found throughout the tropical and subtropical regions of the world. Learn more about these aggressive daytime biters and this disease.

Autochthonous Transmission of Dengue Fever Rising in France
https://www.medscape.com/viewarticle/982823

Oct 21st, 2022 - As of Sept. 20, 2022, 47 autochthonous cases of dengue fever, spread across five clusters, have been reported in mainland France since July. These figures mark an increase in autochthonous transmission on several levels. A record number of cases h...

CDC Advisors Endorse Adding COVID Shots to Vax Schedule
https://www.medpagetoday.com/infectiousdisease/covid19vaccine/101332

Oct 20th, 2022 - The CDC's Advisory Committee on Immunization Practices (ACIP) voted unanimously Thursday to add COVID-19 vaccination to its panel of routine immunizations for both kids and adults. The 15-0 vote does not mandate vaccination for children or adults ...

see more →

Patient Education  21 results see all →